Systemic inflammation and liver injury following hemorrhagic shock and peripheral tissue trauma involve functional TLR9 signaling on bone marrow-derived cells and parenchymal cells

Shock

Volumn 35, Issue 2, 2011, Pages 164-170

  Gill, Roop ^a   Ruan, Xiangcai ^a,b   Menzel, Christoph L ^a   Namkoong, Seung ^a   Loughran, Patricia ^a   Hackam, David J ^a   Billiar, Timothy R ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b GUANGZHOU FIRST PEOPLE'S HOSPITAL   (China)

Author keywords

chimera; damage associated molecular pattern; femur fracture; hemorrhagic shock; TLR9; trauma

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; DNA; INTERLEUKIN 10; INTERLEUKIN 6; TOLL LIKE RECEPTOR 9;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BONE MARROW CELL; CHIMERA; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMUR FRACTURE; HEMORRHAGIC SHOCK; HISTOPATHOLOGY; INJURY SEVERITY; LIVER CELL; LIVER INJURY; LIVER PARENCHYMA; MALE; MOUSE; NONHUMAN; SIGNAL TRANSDUCTION; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

ANIMALS; BONE MARROW CELLS; INFLAMMATION; LIVER; MICE; MICE, MUTANT STRAINS; SHOCK, HEMORRHAGIC; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 9; WOUNDS AND INJURIES;

EID: 78751627334     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/SHK.0b013e3181eddcab     Document Type: Article

References (54)

1. Dewar D, Moore FA, Moore EE, Balogh Z: Postinjury multiple organ failure. Injury 40:912-918, 2009.
2. Lenz A, Franklin GA, Cheadle WG: Systemic inflammation after trauma. Injury 38:1336-1345, 2007.
3. Faist E, Baue AE, Dittmer H, Heberer G: Multiple organ failure in polytrauma patients. J Trauma 23:775-787, 1983. (Pubitemid 13008526)
4. Strecker W, Gebhard F, Rager J, Bruckner UB, Steinbach G, Kinzl L: Early biochemical characterization of soft-tissue trauma and fracture trauma. J Trauma 47:358-364, 1999.
5. Moore EE: Synergy of bone fractures, soft tissue disruption, and hemorrhagic shock in the genesis of postinjury immunochaos: the pathway to multiple organ failure. Crit Care Med 26:1305-1306, 1998.
6. Gahan PB, Swaminathan R: Circulating nucleic acids in plasma and serum. Recent developments. Ann N Y Acad Sci 1137:1-6, 2008.
7. Lam NY, Rainer TH, Chan LY, Joynt GM, Lo YM: Time course of early and late changes in plasma DNA in trauma patients. Clin Chem 49:1286-1291, 2003.
8. Rainer TH, Lo YM, Chan LY, Lam NY, Lit LC, Cocks RA: Derivation of a prediction rule for posttraumatic organ failure using plasma DNA and other variables. Ann N Y Acad Sci 945:211-220, 2001.
9. Rainer TH: Plasma DNA, prediction and post-traumatic complications. Clin Chim Acta 313:81-85, 2001.
10. Zhang Q, Raoof M, Chen Y, Sumi Y, Sursal T, Junger W, Brohi K, Itagaki K, Hauser CJ: Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature 464:104-107, 2010.
11. Lotze MT, Zeh HJ, Rubartelli A, Sparvero LJ, Amoscato AA, Washburn NR, Devera ME, Liang X, Tor M, Billiar TR: The grateful dead: damage-associated molecular pattern molecules and reduction/oxidation regulate immunity. Immunol Rev 220:60-81, 2007.
12. Wang F, Birch SE, He R, Tawadros P, Szaszi K, Kapus A, Rotstein OD: Remote ischemic preconditioning by hindlimb occlusion prevents liver ischemic/ reperfusion injury: the role of High Mobility Group-Box 1. Ann Surg 251: 292-299, 2010.
13. Tsung A, Klune JR, Zhang X, Jeyabalan G, Cao Z, Peng X, Stolz DB, Geller DA, Rosengart MR, Billiar TR: HMGB1 release induced by liver ischemia involves Toll-like receptor 4 dependent reactive oxygen species production and calcium-mediated signaling. J Exp Med 204:2913-2923, 2007.
14. Tsung A, Sahai R, Tanaka H, Nakao A, Fink MP, Lotze MT, Yang H, Li J, Tracey KJ, Geller DA, et al.: The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion. J Exp Med 201:1135-1143, 2005.
15. Li Y, Xiang M, Yuan Y, Xiao G, Zhang J, Jiang Y, Vodovotz, Y, Billiar TR, Wilson MA, Fan J: Hemorrhagic shock augments lung endothelial cell activation: role of temporal alterations of TLR4 and TLR2. Am J Physiol Regul Integr Comp Physiol 297:R1670YR1680, 2009.
16. Shen XD, Ke B, Zhai Y, Gao F, Busuttil RW, Cheng G, Kupiec-Weglinski JW: Toll-like receptor and heme oxygenase-1 signaling in hepatic ischemia/ reperfusion injury. Am J Transplant 5:1793-1800, 2005.
17. Vollmer J: TLR9 in health and disease. Int Rev Immunol 25:155-181, 2005.
18. Lamphier MS, Sirois CM, Verma A, Golenbock DT, Latz E: TLR9 and the recognition of self and non-self nucleic acids. Ann N Y Acad Sci 1082:31-43, 2006.
19. Rifkin IR, Leadbetter EA, Busconi L, Viglianti G, Marshak-Rothstein A: Tolllike receptors, endogenous ligands, and systemic autoimmune disease. Immunol Rev 204:27-42, 2005. (Pubitemid 40460491)
20. Enari M, Sakahira H, Yokoyama H, Okawa K, Iwamatsu A, Nagata S: A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature 391:43-50, 1998.
21. Tian J, Avalos AM, Mao SY, Chen B, Senthil K, Wu H, Parroche P, Drabic S, Golenbock D, Sirois C, et al.: Toll-like receptor 9Ydependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE. Nat Immunol 8:487-496, 2007.
22. Martin-Armas M, Simon-Santamaria J, Pettersen I, Moens U, Smedsrod B, Sveinbjornsson B: Toll-like receptor 9 (TLR9) is present in murine liver sinusoidal endothelial cells (LSECs) and mediates the effect of CpG-oligonucleotides. J Hepatol 44:939-946, 2006.
23. Liu S, Gallo DJ, Green AM, Williams DL, Gong X, Shapiro RA, Gambotto AA, Humphris EL, Vodovotz Y, Billiar TR: Role of Toll-Like receptors in changes in gene expression and NF-{kappa}B activation in mouse hepatocytes stimulated with lipopolysaccharide. Infect Immun 70:3433-3442, 2002.
24. Maher JJ: DAMPs ramp up drug toxicity. J Clin Invest 119:246-249, 2009.
25. Imaeda AB, Watanabe A, Sohail MA, Mahmood S, Mohamadnejad M, Sutterwala FS, Flavell RA, Mehal WZ: Acetaminophen-induced hepatotoxicity in mice is dependent on Tlr9 and the Nalp3 inflammasome. J Clin Invest 119: 305-314, 2009.
26. Bamboat ZM, Ocuin LM, Balachandran VP, Obaid H, Plitas G, DeMatteo RP: Conventional DCs reduce liver ischemia/reperfusion injury in mice via IL-10 secretion. J Clin Invest 120:559-569, 2010.
27. Bamboat ZM, Balachandran VP, Ocuin LM, Obaid H, Plitas G, DeMatteo RP: Toll-like receptor 9 inhibition confers protection from liver ischemia-reperfusion injury. Hepatology 51:621-632, 2010.
28. Tabeta K, Georgel P, Janssen E, Du X, Hoebe K, Crozat K, Mudd S, Shamel L, Sovath S, Goode J, et al.: Toll-like receptors 9 and 3 as essential components of innate immune defense against mouse cytomegalovirus infection. Proc Natl Acad Sci USA 101:3516-3521, 2004.
29. Gribar SC, Sodhi CP, Richardson WM, Anand RJ, Gittes GK, Branca MF, Jakub A, Shi X-h, Shah S, Ozolek JA, et al.: Reciprocal expression and signaling of TLR4 and TLR9 in the pathogenesis and treatment of necrotizing enterocolitis. J Immunol 182:636-646, 2009.
30. Ruan X, Shi H, Xia G, Xiao Y, Dong J, Ming F, Wang S: Encapsulated bifi-dobacteria reduced bacterial translocation in rats following hemorrhagic shock and resuscitation. Nutrition 23:754-761, 2007.
31. Mollen KP, Levy RM, Prince JM, Hoffman RA, Scott MJ, Kaczorowski DJ, Vallabhaneni R, Vodovotz Y, Billiar TR: Systemic inflammation and end organ damage following trauma involves functional TLR4 signaling in both bone marrowYderived cells and parenchymal cells. J Leukoc Biol 83:80-88, 2008.
32. Sherry RM, Cue JI, Goddard JK, Parramore JB, DiPiro JT: Interleukin-10 is associated with the development of sepsis in trauma patients. J Trauma 40: 613-616, 1996.
33. Mollen KP, Anand RJ, Tsung A, Prince JM, Levy RM, Billiar TR: Emerging paradigm: Toll-like receptor 4-sentinel for the detection of tissue damage. Shock 26:430-437, 2006.
34. Levy RM, Prince JM, Yang R, Mollen KP, Liao H, Watson GA, Fink MP, Vodovotz Y, Billiar TR: Systemic inflammation and remote organ damage following bilateral femur fracture requires Toll-like receptor 4. Am J Physiol Regul Integr Comp Physiol 291:R970YR976, 2006.
35. Ertel W, Morrison MH, Ayala A, Chaudry IH: Chloroquine attenuates hemor-rhagic shock-induced immunosuppression and decreases susceptibility to sepsis. Arch Surg 127:70-75, 1992.
36. Makui H, Soares RJ, Jiang W, Constante M, Santos MM: Contribution of Hfe expression in macrophages to the regulation of hepatic hepcidin levels and iron loading. Blood 106:2189-2195, 2005.
37. Liu Y, Yuan Y, Li Y, Zhang J, Xiao G, Vodovotz Y, Billiar TR, Wilson MA, Fan J: Interacting neuroendocrine and innate and acquired immune pathways regulate neutrophil mobilization from bone marrow following hemorrhagic shock. J Immunol 182:572-580, 2009.
38. Klune JR, Dhupar R, Cardinal J, Billiar TR, Tsung A: HMGB1: endogenous danger signaling. Mol Med 14:476-484, 2008.
39. Barton GM, Kagan JC, Medzhitov R: Intracellular localization of Toll-like receptor 9 prevents recognition of self DNA but facilitates access to viral DNA. Nat Immunol 7:49-56, 2006.
40. Horng T, Barton GM, Flavell RA, Medzhitov R: The adaptor molecule TIRAP provides signalling specificity for Toll-like receptors. Nature 420:329-333, 2002.
41. Kaczorowski DJ, Mollen KP, Edmonds R, Billiar TR: Early events in the recognition of danger signals after tissue injury. J Leukoc Biol 83:546-552, 2008.
42. Prince JM, Levy RM, Yang R, Mollen KP, Fink MP, Vodovotz Y, Billiar TR: Toll-like receptor-4 signaling mediates hepatic injury and systemic inflammation in hemorrhagic shock. J Am Coll Surg 202:407-417, 2006.
43. Hoth JJ, Hudson WP, Brownlee NA, Yoza BK, Hiltbold EM, Meredith JW, McCall CE: Toll-like receptor 2 participates in the response to lung injury in a murine model of pulmonary contusion. Shock 28:447-452, 2007.
44. Levy RM, Mollen KP, Prince JM, Kaczorowski DJ, Vallabhaneni R, Liu S, Tracey KJ, Lotze MT, Hackam DJ, Fink MP, et al.: Systemic inflammation and remote organ injury following trauma require HMGB1. Am J Physiol Regul Integr Comp Physiol 293:R1538YR1544, 2007.
45. Cairns BA, Barnes CM, Mlot S, Meyer AA, Maile R: Toll-like receptor 2 and 4 ligation results in complex altered cytokine profiles early and late after burn injury. J Trauma 64:1069-1077, 2008.
46. Lo YM, Chiu RW: The biology and diagnostic applications of plasma RNA. Ann N Y Acad Sci 1022:135-139, 2004.
47. Saukkonen K, Lakkisto P, Varpula M, Varpula T, Voipio-Pulkki LM, Pettila V, Pulkki K: Association of cell-free plasma DNA with hospital mortality and organ dysfunction in intensive care unit patients. Intensive Care Med 33: 1624-1627, 2007.
48. Wijeratne S, Butt A, Burns S, Sherwood K, Boyd O, Swaminathan R: Cell-free plasma DNA as a prognostic marker in intensive treatment unit patients. Ann N Y Acad Sci 1022:232-238, 2004.
49. Kaczorowski DJ, Tsung A, Billiar TR: Innate immune mechanisms in ischemia/ reperfusion. Front Biosci (Elite Ed) 1:91-98, 2009.
50. Chen GY, Tang J, Zheng P, Liu Y: CD24 and Siglec-10 selectively repress tissue damage-induced immune responses. Science 323:1722-1725, 2009.
51. Ivanov S, Dragoi AM, Wang X, Dallacosta C, Louten J, Musco G, Sitia G, Yap GS, Wan Y, Biron CA, et al.: A novel role for HMGB1 in TLR9-mediated inflammatory responses to CpG-DNA. Blood 110:1970-1981, 2007.
52. Margraf S, Logters T, Reipen J, Altrichter J, Scholz M, Windolf J: Neutrophil-derived circulating free DNA (cf-DNA/NETs): a potential prognostic marker for posttraumatic development of inflammatory second hit and sepsis. Shock 30:352-358, 2008.
53. Butt AN, Swaminathan R: Overview of circulating nucleic acids in plasma/ serum. Ann N Y Acad Sci 1137:236-342, 2008.
54. Miura K, Kodama Y, Inokuchi S, Schnabl B, Aoyama T, Ohnishi H, Olefsky JM, Brenner DA, Seki E: Toll-like receptor 9 promotes steatohepatitis by induction of interleukin-1[beta] in Mice. Gastroenterology 139:323-334, 2010.